Sponsored Symposias

All symposias will be held in-person at the Melbourne Convention and Exhibition Centre.

Please click on the plus (+) button next to each symposia title for more information.

Saturday, 20 September, 2025

S1MPLIFY UC
UC – An Integrative Approach

Saturday 20 September
7:15am - 8:15am
Meeting Room 216

Sponsored by

  • Join the Pfizer breakfast symposium at AGW 2025 with international expert Prof Millie Long and local experts Prof Rupert Leong & A/Prof Britt Christensen – join our experts for an engaging review of Ulcerative Colitis from setting treatment goals to long-term management, illustrated with interactive case studies and featuring practical guidance

    • Prof Rupert Leong – Director of Endoscopy and Head of Inflammatory Bowel Disease Services, Concord Hospital

    • A/Prof Britt Christensen – Head of Inflammatory Bowel Disease, Royal Melbourne Hospital

    • Prof Millie Long – Professor of Medicine and Chief, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill

ERCP and EUS at the crossroads

Saturday 20 September
7:15am - 8:15am
Meeting Room 208

Sponsored by

  • ERCP and EUS have evolved from primarily diagnostic tools into powerful, minimally invasive therapeutic platforms. As their capabilities expand, these two modalities increasingly intersect in the management of pancreaticobiliary diseases. This breakfast session will explore the current landscape where ERCP and EUS converge, overlap, and complement each other, highlighting advancements that are reshaping clinical pathways.

    Interactive discussions will examine clinical decision-making in scenarios where either modality could be employed, with emphasis on patient safety, procedural outcomes, and resource utilization. The meeting will also highlight training challenges and the need for structured competency development in advanced endoscopy.

    By bringing together leaders in the field, this symposium aims to foster a collaborative vision for the future of pancreaticobiliary endoscopy—where ERCP and EUS are not in competition, but part of a dynamic, integrated toolkit to optimize patient care.

    • Prof Krish Ragunath - Royal Perth Hospital

    • Dr Nageshwar Reddy - Asian Institute of Gastroenterology & AIG Hospitals

Emerging Frontiers in IBD Treatment: The evolution, revolution and transformation of IBD Care

Saturday 20 September
6:00pm - 7:30pm
Meeting Room 208

Sponsored by

  • Join us for the symposium, "Emerging Frontiers in IBD Treatment: The Evolution, Revolution, and Transformation of IBD Care," designed specifically for gastroenterologists and healthcare professionals working in the area of IBD. Hosted by AbbVie, this event brings together leading experts A/Prof Britt Christensen, Prof Michael Kamm, and A/Prof Jacob Begun to provide insights into the rapidly evolving landscape of inflammatory bowel disease treatment.

    The symposium will explore the progression from conventional therapies to advanced treatments like RINVOQ, which have greatly influenced treatment protocols and improved patient outcomes. Engage in thought-provoking discussions covering the evolution of treatment guidelines, the impact of personalised medicine, and the role of the latest clinical trials in shaping IBD care.

    Don't miss this opportunity to connect with fellow professionals, gain insights into groundbreaking therapies, and discuss the future directions of IBD treatment. For further details, please reach out to your AbbVie representative.

    • Dr Alvin Quah

    • Prof Michael Kamm

    • A/Prof Jake Begun

    • Britt Christensen

Sunday, 21 September, 2025

Innovations in IPCE: Driving Access, Efficiency and Quality in Healthcare

Sunday 21 September
7:15am - 8:15am
Meeting Room 208

Sponsored by

  • An Urban, Regional, and Global Perspective

    This session highlights a purpose-built facility delivering pre-sterilised, ready-to-use endoscopes - advancing infection prevention, supporting regional healthcare access and enabling high-volume data collection to drive research.

    • Prof Benedict Devereaux- Royal Brisbane and Women’s Hospital

    • Ms Di Jones- ANZGITA

    • Dr Mehul Lamba- Christchurch Hospital

    • Ms Grace Loh- Western Australia Country Health Service

Advances in MASH care: from patient identification to cardiometabolic management

Sunday 21 September
7:15am - 8:15am
Meeting Room 209

Sponsored by

  • Join international expert Prof. Emmanuel Tsochatzis (UK), along with Prof. Leon Adams and A/Prof. Sam Hocking (endocrinologist), for an engaging and interactive multidisciplinary breakfast symposium. This session will delve into the latest advances in metabolic dysfunction-associated steatohepatitis (MASH) clinical care, from patient identification to future therapeutic approaches.

     

    As local and international screening and management guidelines continue to evolve, the need to risk-stratify individuals with steatotic liver disease using non-invasive tests (NITs) across primary and specialist care is becoming increasingly important. Learn about the latest evidence shaping the identification of at-risk individuals with NITs, discuss which referral pathways may be suitable to implement in your clinical practice and explore the therapeutic horizon for optimising the cardiometabolic management of people living with MASH. 

    • Prof Krish Ragunath - Royal Perth Hospital

    • Dr Nageshwar Reddy - Asian Institute of Gastroenterology & AIG Hospitals

Trials to Treatment: Exploring Guselkumab’s Impact in Crohn’s Disease with Insights from Prof. Millie Long

Sunday 21 September
7:15am - 8:15am
Meeting Room 210

Sponsored by

Elevating Possibilities in PBC: Emerging new therapies

Sunday 21 September
7:15am - 8:15am
Meeting Room 203&204

Sponsored by Gilead

  • Join us at WCOG@AGW25 for an engaging Breakfast Symposium with International Speaker Prof. Millie long who will present on key findings from the pivotal GALAXI and GRAVITI studies on guselkumab in Crohn's disease. Prof. Long will provide a comprehensive summary of these landmark trials and share her valuable real-world experience using guselkumab in the US. Don’t miss this opportunity to deepen your understanding of emerging treatment options and clinical insights!

    • TBC

    • Prof Millie Long

  • PBC Scientific Exchange Symposium including a discussion on current unmet needs, evolving treatment goals and emerging new therapeutic options in 2L setting. A facilitated interactive group discussion including the patient perspective will discuss optimal patient management

    • Prof Alex Thompson, St. Vincent’s Hospital Melbourne

    • Prof Nancy Reau, Chief of Hepatology, and Associate Director of Solid Organ Transplantation at Rush University Medical Center in Chicago

    • A/Prof Martin Weltman, Head of Gastroenterology and Hepatology Nepean Hospital

    • Dr Rohit Gupta, Sunshine Coast University Hospital

    • A/Prof Siddharth Sood, Head of Hepatology, Department of Gastroenterology, Northern Health